{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:42:32Z","timestamp":1709858552443},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,7]]},"DOI":"10.7759\/cureus.55734","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:41:19Z","timestamp":1709836879000},"source":"Crossref","is-referenced-by-count":0,"title":["The Frequency of Intraocular Pressure Elevation, Incidence of Secondary Glaucoma, and Surgical Treatment With Postoperative Complications in Pediatric and Adult Patients With Uveitis"],"prefix":"10.7759","author":[{"given":"Cem","family":"Evereklioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fclay","family":"Karacan Er\u015fekerci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice K\u00fcbra","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidayet","family":"Sener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"Gulmez Sevim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman Ahmet","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Arda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Horozoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.22336\/rjo.2022.59","article-title":"Analysis of altmetrics and additional metrics of the 50 most-cited Beh\u00e7et articles of all time: a Web of Science-based study","volume":"66","author":"Evereklioglu C","year":"2022","unstructured":"Evereklioglu C, Sener H, Horozo\u011flu F. Analysis of altmetrics and additional metrics of the 50 most-cited Beh\u00e7et articles of all time: a Web of Science-based study. Rom J Ophthalmol. 2022, 66:326-36. 10.22336\/rjo.2022.59","journal-title":"Rom J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29930","article-title":"An analysis of the 50 most-cited \"uveitis\" articles published between 2010-2020: from a bibliographic and altmetric perspective","volume":"14","author":"Sener H","year":"2022","unstructured":"Sener H, Evereklioglu C, Horozoglu F. An analysis of the 50 most-cited \"uveitis\" articles published between 2010-2020: from a bibliographic and altmetric perspective. Cureus. 2022, 14:e29930. 10.7759\/cureus.29930","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-023-00324-7","article-title":"Comment on: intraocular lymphoma masquerading as unilateral hypopyon anterior uveitis: a case report","volume":"13","author":"Evereklioglu C","year":"2023","unstructured":"Evereklioglu C, Sener H, Polat OA, Horozoglu F. Comment on: intraocular lymphoma masquerading as unilateral hypopyon anterior uveitis: a case report. J Ophthalmic Inflamm Infect. 2023, 13:8. 10.1186\/s12348-023-00324-7","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002214","article-title":"Bilateral acute iris transillumination and elevated intraocular pressure after COVID-19 infection","volume":"32","author":"Gulmez Sevim D","year":"2023","unstructured":"Gulmez Sevim D, Sener H, Evereklioglu C. Bilateral acute iris transillumination and elevated intraocular pressure after COVID-19 infection. J Glaucoma. 2023, 32:e56-9. 10.1097\/IJG.0000000000002214","journal-title":"J Glaucoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.103209","article-title":"Optic nerve head vessel density using OCTA in patients with primary angle closure disease: a systematic review and network meta-analysis","volume":"41","author":"Sener H","year":"2023","unstructured":"Sener H, Evereklioglu C, Horozoglu F, Sener AB. Optic nerve head vessel density using OCTA in patients with primary angle closure disease: a systematic review and network meta-analysis. Photodiagnosis Photodyn Ther. 2023, 41:103209. 10.1016\/j.pdpdt.2022.103209","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/112067210201200405","article-title":"Effects of L-NAME and timolol on aqueous IL-1beta, IL-6, IL-8, TNF-alpha and NO levels after Nd:YAG laser iridotomy in rabbits","volume":"12","author":"Er H","year":"2002","unstructured":"Er H, Doganay S, Evereklioglu C, Cekmen M, Daglioglu MC, Isci N. Effects of L-NAME and timolol on aqueous IL-1beta, IL-6, IL-8, TNF-alpha and NO levels after Nd:YAG laser iridotomy in rabbits. Eur J Ophthalmol. 2002, 12:281-6. 10.1177\/112067210201200405","journal-title":"Eur J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31066","article-title":"Computed tomographic thickness of retrobulbar optic nerve \u0131s decreased in glaucoma patients and \u0131s negatively correlated with disease severity","volume":"14","author":"Evereklioglu C","year":"2022","unstructured":"Evereklioglu C, Gulmez Sevim D, Horozoglu F, Polat OA, Sener H, Coskun A, Ozturk A. Computed tomographic thickness of retrobulbar optic nerve \u0131s decreased in glaucoma patients and \u0131s negatively correlated with disease severity. Cureus. 2022, 14:e31066. 10.7759\/cureus.31066","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000528593","article-title":"Twenty years of quiescence after nonstop Remicade(\u00ae) (infliximab) infusions in a child with ocular Beh\u00e7et disease presenting as hypopyon-anterior uveitis refractory to immunosuppressants","volume":"14","author":"Evereklioglu C","year":"2023","unstructured":"Evereklioglu C. Twenty years of quiescence after nonstop Remicade(\u00ae) (infliximab) infusions in a child with ocular Beh\u00e7et disease presenting as hypopyon-anterior uveitis refractory to immunosuppressants. Case Rep Ophthalmol. 2023, 14:75-82. 10.1159\/000528593","journal-title":"Case Rep Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2022.2157288","article-title":"Efficacy and safety of adalimumab in patients with Beh\u00e7et uveitis: a systematic review and meta-analysis","volume":"32","author":"Sener H","year":"2024","unstructured":"Sener H, Evereklioglu C, Horozoglu F, Gunay Sener AB. Efficacy and safety of adalimumab in patients with Beh\u00e7et uveitis: a systematic review and meta-analysis. Ocul Immunol Inflamm. 2024, 32:89-97. 10.1080\/09273948.2022.2157288","journal-title":"Ocul Immunol Inflamm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2022.2139274","article-title":"Prompt and sustained suppression of intraocular inflammation with adalimumab in pediatric patients with non-infectious uveitis resistant to traditional managements: a 6-month follow-up research","volume":"31","author":"Sonmez HK","year":"2023","unstructured":"Sonmez HK, Evereklioglu C, Gulmez Sevim D. Prompt and sustained suppression of intraocular inflammation with adalimumab in pediatric patients with non-infectious uveitis resistant to traditional managements: a 6-month follow-up research. Ocul Immunol Inflamm. 2023, 31:1992-6. 10.1080\/09273948.2022.2139274","journal-title":"Ocul Immunol Inflamm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt RB","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985, 92:467-71. 10.1016\/s0161-6420(85)34001-0","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs DA","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005, 140:509-16. 10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200404000-00003","article-title":"Risk factors for elevated intraocular pressure in uveitis","volume":"13","author":"Herbert HM","year":"2004","unstructured":"Herbert HM, Viswanathan A, Jackson H, Lightman SL. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004, 13:96-9. 10.1097\/00061198-200404000-00003","journal-title":"J Glaucoma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.74.4.223","article-title":"Glaucoma in patients with uveitis","volume":"74","author":"Panek WC","year":"1990","unstructured":"Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol. 1990, 74:223-7. 10.1136\/bjo.74.4.223","journal-title":"Br J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200412000-00002","article-title":"Incidence of secondary glaucoma in Beh\u00e7et disease","volume":"13","author":"Elgin U","year":"2004","unstructured":"Elgin U, Berker N, Batman A. Incidence of secondary glaucoma in Beh\u00e7et disease. J Glaucoma. 2004, 13:441-4. 10.1097\/00061198-200412000-00002","journal-title":"J Glaucoma"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-023-02688-0","article-title":"Incidence and pre\/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease","volume":"43","author":"Yoshitomi S","year":"2023","unstructured":"Yoshitomi S, Harada Y, Hiyama T, Yuasa Y, Hirooka K, Kiuchi Y. Incidence and pre\/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2023, 43:2857-66. 10.1007\/s10792-023-02688-0","journal-title":"Int Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-02975-9","article-title":"Effect of adalimumab on choroidal thickness and choroidal vascularity index in eyes with non-infectious uveitis using enhanced-depth imaging optical coherence tomography","author":"Evereklioglu C","year":"2024","unstructured":"Evereklioglu C, Er Arslantas E, Sener H, et al.. Effect of adalimumab on choroidal thickness and choroidal vascularity index in eyes with non-infectious uveitis using enhanced-depth imaging optical coherence tomography. Eye (Lond). 2024, 10.1038\/s41433-024-02975-9","journal-title":"Eye (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-023-02846-4","article-title":"Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Beh\u00e7et syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation","volume":"43","author":"Evereklioglu C","year":"2023","unstructured":"Evereklioglu C, Sonmez HK, Sevim DG, Arda H, Sener H, Polat OA, Horozoglu F. Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Beh\u00e7et syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation. Int Ophthalmol. 2023, 43:4461-72. 10.1007\/s10792-023-02846-4","journal-title":"Int Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2020.01.002","article-title":"Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management","volume":"65","author":"Roberti G","year":"2020","unstructured":"Roberti G, Oddone F, Agnifili L, et al.. Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management. Surv Ophthalmol. 2020, 65:458-72. 10.1016\/j.survophthal.2020.01.002","journal-title":"Surv Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.10.013","article-title":"Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response","volume":"149","author":"Nazm N","year":"2010","unstructured":"Nazm N, Dubey S, Gandhi M, Pegu J. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response. Am J Ophthalmol. 2010, 149:525-6. 10.1016\/j.ajo.2009.10.013","journal-title":"Am J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-5155(02)00549-x","article-title":"A clinical evaluation of uveitis-associated secondary glaucoma","volume":"46","author":"Takahashi T","year":"2002","unstructured":"Takahashi T, Ohtani S, Miyata K, Miyata N, Shirato S, Mochizuki M. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002, 46:556-62. 10.1016\/s0021-5155(02)00549-x","journal-title":"Jpn J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.02.032","article-title":"Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response","volume":"148","author":"Sallam A","year":"2009","unstructured":"Sallam A, Sheth HG, Habot-Wilner Z, Lightman S. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response. Am J Ophthalmol. 2009, 148:207-13.e1. 10.1016\/j.ajo.2009.02.032","journal-title":"Am J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2001.00427.x","article-title":"Nd:YAG laser iridotomy in uveitic glaucoma","volume":"29","author":"Spencer NA","year":"2001","unstructured":"Spencer NA, Hall AJ, Stawell RJ. Nd:YAG laser iridotomy in uveitic glaucoma. Clin Exp Ophthalmol. 2001, 29:217-9. 10.1046\/j.1442-9071.2001.00427.x","journal-title":"Clin Exp Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000027428","article-title":"A major review of antimetabolites in glaucoma therapy","volume":"213","author":"Loon SC","year":"1999","unstructured":"Loon SC, Chew PT. A major review of antimetabolites in glaucoma therapy. Ophthalmologica. 1999, 213:234-45. 10.1159\/000027428","journal-title":"Ophthalmologica"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200206000-00005","article-title":"Trabeculectomy with antiproliferative agents in uveitic glaucoma","volume":"11","author":"Ceballos EM","year":"2002","unstructured":"Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma. 2002, 11:189-96. 10.1097\/00061198-200206000-00005","journal-title":"J Glaucoma"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000146624.31345.33","article-title":"Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Beh\u00e7et disease","volume":"13","author":"Yalvac IS","year":"2004","unstructured":"Yalvac IS, Sungur G, Turhan E, Eksioglu U, Duman S. Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Beh\u00e7et disease. J Glaucoma. 2004, 13:450-3. 10.1097\/01.ijg.0000146624.31345.33","journal-title":"J Glaucoma"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181ca7850","article-title":"What is new after 40 years of glaucoma implants","volume":"19","author":"Freedman J","year":"2010","unstructured":"Freedman J. What is new after 40 years of glaucoma implants. J Glaucoma. 2010, 19:504-8. 10.1097\/IJG.0b013e3181ca7850","journal-title":"J Glaucoma"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000243479.90403.cd","article-title":"Comparison of trabeculectomy with Ex-PRESS miniature glaucoma device implanted under scleral flap","volume":"16","author":"Maris PJ Jr","year":"2007","unstructured":"Maris PJ Jr, Ishida K, Netland PA. Comparison of trabeculectomy with Ex-PRESS miniature glaucoma device implanted under scleral flap. J Glaucoma. 2007, 16:14-9. 10.1097\/01.ijg.0000243479.90403.cd","journal-title":"J Glaucoma"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235620-the-frequency-of-intraocular-pressure-elevation-incidence-of-secondary-glaucoma-and-surgical-treatment-with-postoperative-complications-in-pediatric-and-adult-patients-with-uveitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:41:22Z","timestamp":1709836882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235620-the-frequency-of-intraocular-pressure-elevation-incidence-of-secondary-glaucoma-and-surgical-treatment-with-postoperative-complications-in-pediatric-and-adult-patients-with-uveitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.55734","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}